v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2024   386      
Balance at beginning of period at Dec. 31, 2024 $ 10,901 $ 0 $ 866 $ (10) $ 10,045
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock units (in shares)   3      
Exercise of options to purchase common stock 5   5    
Tax payments related to net share settlements on equity awards     (1)    
Issuance of common stock under employee stock purchase plan 12   12    
Stock-based compensation 245   245    
Other comprehensive (loss) income, net of tax 33     33  
Net loss (1,796)       (1,796)
Balance at end of period (in shares) at Jun. 30, 2025   389      
Balance at end of period at Jun. 30, 2025 9,399 $ 0 1,127 23 8,249
Balance at beginning of period (in shares) at Mar. 31, 2025   387      
Balance at beginning of period at Mar. 31, 2025 10,066 $ 0 982 10 9,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock units (in shares)   2      
Exercise of options to purchase common stock 3   3    
Issuance of common stock under employee stock purchase plan 12   12    
Stock-based compensation 130   130    
Other comprehensive (loss) income, net of tax 13     13  
Net loss (825)       (825)
Balance at end of period (in shares) at Jun. 30, 2025   389      
Balance at end of period at Jun. 30, 2025 $ 9,399 $ 0 1,127 23 8,249
Balance at beginning of period (in shares) at Dec. 31, 2025 394 394      
Balance at beginning of period at Dec. 31, 2025 $ 8,650 $ 0 1,382 45 7,223
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) income, net of tax (20)        
Balance at end of period (in shares) at Mar. 31, 2026   397      
Balance at end of period at Mar. 31, 2026 $ 7,408 $ 0 1,503 25 5,880
Balance at beginning of period (in shares) at Dec. 31, 2025 394 394      
Balance at beginning of period at Dec. 31, 2025 $ 8,650 $ 0 1,382 45 7,223
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock units (in shares)   3      
Exercise of options to purchase common stock (in shares)   2      
Exercise of options to purchase common stock 32   32    
Tax payments related to net share settlements on equity awards     (4)    
Issuance of common stock under employee stock purchase plan 10   10    
Stock-based compensation 224   224    
Other comprehensive (loss) income, net of tax (26)     (26)  
Net loss $ (2,125)       (2,125)
Balance at end of period (in shares) at Jun. 30, 2026 399 399      
Balance at end of period at Jun. 30, 2026 $ 6,761 $ 0 1,644 19 5,098
Balance at beginning of period (in shares) at Mar. 31, 2026   397      
Balance at beginning of period at Mar. 31, 2026 7,408 $ 0 1,503 25 5,880
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock units (in shares)   1      
Exercise of options to purchase common stock (in shares)   1      
Exercise of options to purchase common stock 13   13    
Tax payments related to net share settlements on equity awards (2)   (2)    
Issuance of common stock under employee stock purchase plan 10   10    
Stock-based compensation 120   120    
Other comprehensive (loss) income, net of tax (6)     (6)  
Net loss $ (782)       (782)
Balance at end of period (in shares) at Jun. 30, 2026 399 399      
Balance at end of period at Jun. 30, 2026 $ 6,761 $ 0 $ 1,644 $ 19 $ 5,098